Capital Investment Advisors’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,758
Closed -$286K 705
2024
Q3
$286K Buy
15,758
+730
+5% +$12.7K 0.01% 526
2024
Q2
$363K Sell
15,028
-4,238
-22% -$132K 0.01% 463
2024
Q1
$840K Sell
19,266
-425
-2% -$17.6K 0.02% 313
2023
Q4
$803K Sell
19,691
-7
-0% -$381 0.02% 300
2023
Q3
$1.63M Buy
19,698
+1,002
+5% +$90.9K 0.05% 203
2023
Q2
$1.78M Hold
18,696
0.05% 176
2023
Q1
$2.58M Sell
18,696
-12
-0.1% -$1.1K 0.08% 149
2022
Q4
$1.34M Sell
18,708
-2,127
-10% -$201K 0.04% 211
2022
Q3
$2.46M Buy
20,835
+60
+0.3% +$10.7K 0.08% 152
2022
Q2
$3.79M Buy
20,775
+75
+0.4% +$13.6K 0.13% 128
2022
Q1
$4.85M Buy
20,700
+320
+2% +$64.6K 0.15% 119
2021
Q4
$6.95M Buy
20,380
+97
+0.5% +$53.4K 0.21% 98
2021
Q3
$13.3M Buy
20,283
+14,184
+233% +$10.4M 0.45% 53
2021
Q2
$6.11M Buy
6,099
+5,065
+490% +$5.05M 0.21% 94
2021
Q1
$1.56M Buy
+1,034
New +$1.68M 0.06% 199

Other funds holding DNMR

Capital Investment Advisors's DNMR Position: Q4 2024 in Review

Capital Investment Advisors sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 15,758 shares — an estimated $286K sold.

Capital Investment Advisors first reported a position in DNMR in Q1 2021 and held it in 15 quarters. The position peaked at $13.3M in Q3 2021. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • Capital Investment Advisors reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • Capital Investment Advisors sold 15,758 Danimer Scientific, Inc. shares in Q4 2024, an estimated $286K.
  • Capital Investment Advisors first reported a position in Danimer Scientific, Inc. in Q1 2021 and held it in 15 quarters.
  • Capital Investment Advisors's Danimer Scientific, Inc. position peaked at $13.3M in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Capital Investment Advisors's 13F filing for Q4 2024, filed 13 Jan 2025.